Trilogy Capital’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $215K | Sell |
4,638
-740
| -14% | -$34.3K | 0.01% | 353 |
|
|
2025
Q1 | $328K | Sell |
5,378
-18,732
| -78% | -$1.14M | 0.02% | 268 |
|
|
2024
Q4 | $1.36M | Sell |
24,110
-42,012
| -64% | -$2.38M | 0.07% | 164 |
|
|
2024
Q3 | $3.42M | Buy |
66,122
+419
| +0.6% | +$21.7K | 0.17% | 93 |
|
|
2024
Q2 | $2.73M | Buy |
65,703
+5,219
| +9% | +$217K | 0.15% | 112 |
|
|
2024
Q1 | $3.28M | Buy |
60,484
+7,678
| +15% | +$416K | 0.19% | 90 |
|
|
2023
Q4 | $2.71M | Buy |
52,806
+3,181
| +6% | +$163K | 0.17% | 102 |
|
|
2023
Q3 | $2.88M | Buy |
49,625
+42,287
| +576% | +$2.45M | 0.2% | 74 |
|
|
2023
Q2 | $475K | Buy |
7,338
+1,671
| +29% | +$108K | 0.03% | 175 |
|
|
2023
Q1 | $393K | Buy |
5,667
+1,108
| +24% | +$76.8K | 0.03% | 170 |
|
|
2022
Q4 | $328K | Buy |
4,559
+853
| +23% | +$61.4K | 0.02% | 189 |
|
|
2022
Q3 | $263K | Sell |
3,706
-6
| -0.2% | -$426 | 0.02% | 157 |
|
|
2022
Q2 | $286K | Buy |
3,712
+221
| +6% | +$17K | 0.02% | 135 |
|
|
2022
Q1 | $255K | Buy |
+3,491
| New | +$255K | 0.02% | 155 |
|
|
2018
Q4 | – | Sell |
-523
| Closed | -$32K | – | 188 |
|
|
2018
Q3 | $32K | Buy |
523
+142
| +37% | +$8.69K | ﹤0.01% | 230 |
|
|
2018
Q2 | $21K | Buy |
381
+81
| +27% | +$4.47K | ﹤0.01% | 244 |
|
|
2018
Q1 | $19K | Buy |
+300
| New | +$19K | ﹤0.01% | 225 |
|